ask="1.50"
ask_size="1000"
average_daily_volume="282267"
bid="1.13"
bid_size="2000"
book_value="0.51"
change="-0.03"
change_from_200_day_moving_average="0.07"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-1.55"
change_From_52_week_low="0.44"
change_in_percent="-2.19%"
close="1.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="0.00"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-1.00"
ex_dividend_date="N/A"
float_shares="12508000"
high="1.42"
high_52_weeks="2.89"
last_trade_date="3/7/2017"
last_trade_price="1.34"
last_trade_size="210"
last_trade_time="4:00pm"
low="1.31"
low_52_weeks="0.90"
market_capitalization="27.03M"
moving_average_200_day="1.27"
moving_average_50_day="1.46"
name="Viking Therapeutics
Inc."
notes="N/A"
one_year_target_price="7.56"
open="1.38"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+5.31%"
percent_change_from_50_day_moving_average="-8.43%"
percent_change_from_52_week_high="-53.63%"
percent_change_from_52_week_low="+48.72%"
previous_close="1.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.67"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20170000"
short_ratio="2.53"
stock_exchange="NCM"
symbol="VKTX"
volume="119162"
weeks_range_52="0.90 - 2.89"
